Medical Cannabis Advocacy in Australia and New Zealand During the 1990s

Legal and medical context at the start of the 1990s

Cannabis was prohibited under criminal law in every Australian state and in New Zealand at the start of the 1990s Strong evidence^[1][2]. Possession and cultivation were prosecuted under the Commonwealth Customs Act, state Drug Misuse Acts, and New Zealand's Misuse of Drugs Act 1975 Strong evidence^[2]. Some jurisdictions had begun reducing penalties for personal possession—South Australia introduced an expiation (on-the-spot fine) scheme for small amounts in 1987, followed by the Australian Capital Territory in 1992 and the Northern Territory in 1996—but none of these reforms addressed medical use Weak / limited^[3].

The Australian and New Zealand medical establishments did not recognise cannabis as having a legitimate therapeutic role. This mirrored the position held by international regulatory bodies at the time. No pharmaceutical cannabinoid products were registered in either country: dronabinol (Marinol) was available in the United States but not licensed in Australasia, and nabiximols (Sativex) would not be developed until the late 1990s. The conversation about medical cannabis was driven almost entirely from outside official medical channels.

HIV/AIDS and harm reduction as the primary advocacy driver

From the late 1980s into the mid-1990s, HIV-positive Australians and New Zealanders used cannabis to manage specific antiretroviral side effects—nausea and appetite loss from early medications including AZT, and wasting syndrome Weak / limited^[4]. This pattern mirrored the situation in San Francisco and New York, where AIDS patients had become visible advocates for medical access Anecdote.

Australian AIDS Councils in Sydney, Melbourne and the Australian Federation of AIDS Organisations (AFAO) acknowledged this use in harm-reduction materials and internal policy discussions, though they did not formally endorse cannabis as a treatment Weak / limited^[4]. The key policy lever was the National HIV/AIDS Strategy framework (1996–1998), which had bipartisan political support and gave HIV advocates unusual access to government health departments. Medical cannabis appeared in serious Commonwealth health documents for the first time not as a standalone reform proposal but as a harm-reduction question embedded within HIV policy Strong evidence^[4]. When combination antiretroviral therapy became widely available in 1996–1997, the acute urgency of this specific advocacy line diminished, but by then the topic had entered broader public and media debate.

Key organisations and figures

Australia. The HEMP (Help End Marijuana Prohibition) Party was founded in 1993 by Michael Balderstone and others at the Nimbin MardiGrass festival, blending recreational law reform with medical advocacy^[5]. Dr Alex Wodak, director of the Alcohol and Drug Service at St Vincent's Hospital Sydney, emerged as the most prominent medical voice arguing publicly for both harm reduction and legitimate medical access to cannabis Weak / limited^[6]. Wodak co-founded the Australian Drug Law Reform Foundation, which made cannabis law reform a recurring focus.

New Zealand. NORML New Zealand, active since 1979, ran patient-focused campaigns throughout the 1990s and published Norml News, which collected patient testimony and advocacy pieces Weak / limited^[7]. The Aotearoa Legalise Cannabis Party (ALCP) was registered in 1996 and contested the 1996 general election under the new Mixed Member Proportional (MMP) voting system, receiving 1.66% of the party vote—the first cannabis-focused party to contest an Australasian general election under proportional representation Strong evidence^[8].

A recurring myth attributes the decade's advocacy momentum to a single charismatic patient-activist who "almost got medical cannabis legalised" in one or both countries Anecdote. No such moment appears in the contemporaneous Hansard records, government cabinet papers or major press coverage. Advocacy was diffuse, incremental and primarily driven by organisations and networks rather than individual figures.

Government inquiries and commissioned reviews

Two government processes from this period warrant examination.

The National Task Force on Cannabis, established by the Commonwealth Department of Human Services and Health, released a major review in 1994 (The Health and Psychological Consequences of Cannabis Use, authored by Wayne Hall, Nadia Solowij and James Lemon) Strong evidence^[9]. The review was primarily a health-effects assessment rather than a medical-use assessment, but it acknowledged published research on cannabis for nausea, glaucoma and spasticity and explicitly called for more research—a departure from earlier government documents that had treated cannabis as having no medical value Strong evidence^[9].

In New South Wales, Premier Bob Carr commissioned a Working Party on the Use of Cannabis for Medical Purposes in the late 1990s, which reported in August 2000 Strong evidence^[10]. Though the report technically fell outside the 1990s, it was a direct institutional response to late-1990s advocacy pressure. The working party recommended a controlled trial allowing patients with specified conditions (chronic pain, nausea from cancer treatment, MS spasticity, epilepsy) to use cannabis without criminal penalty. The NSW government accepted these recommendations in principle in 2003 but never enacted or implemented the trial scheme—a pattern of recommendation without implementation that would persist across Australasia for another decade Strong evidence^[10].

Myths and disputed claims from the era

Several persistent claims about 1990s advocacy do not survive scrutiny of the primary record:

"Medical cannabis was about to be legalised in NSW in 2000." The NSW Working Party recommended a trial scheme under strict conditions, not legalisation, and no trial ever took place Disputed^[10]. The government accepted the recommendation in principle but did not resource or legislate the trial.

"Helen Clark's Labour government nearly decriminalised cannabis." The Health Select Committee inquiry that produced a 1998 report on cannabis policy was initiated under the National-led government. The report's recommendations were modest—primarily calls for further research and harm-reduction focused policy adjustment. Subsequent Labour governments did not advance decriminalisation proposals Disputed^[11].

"Nimbin had de facto medical dispensaries in the 1990s." Nimbin hosted the annual MardiGrass festival and the HEMP Embassy, and operated as an open cannabis market, but no documented medical-focused dispensing operation comparable to the San Francisco Cannabis Buyers' Clubs of the 1990s has been recorded in primary sources or contemporary journalism Weak / limited^[5].

The broader "near-miss" narrative. The 1990s are often characterised as a near-miss for legal medical access—a decade when reform almost happened but was narrowly defeated. The primary record shows a different picture: advocacy infrastructure was built, medical practitioners began engaging with the question, and government inquiries acknowledged therapeutic potential, but no government or parliament genuinely approached a vote on medical access. The decade's real legacy was establishing the vocabulary, networks and institutional memory that enabled actual legislative reform in the 2010s Weak / limited.

Legacy and the path to 2010s reform

Australia did not establish a federal medicinal cannabis access scheme until the Narcotic Drugs Amendment Act 2016 Strong evidence^[12]. New Zealand's Misuse of Drugs (Medicinal Cannabis) Amendment Act passed in 2018 Strong evidence^[13]. By these dates, most of the 1990s activists and organisers were retired, deceased or focused on other causes. The successful reformers of the 2010s—patient parents campaigning for paediatric epilepsy access, palliative care physicians, and a new generation of politicians—built on the 1990s infrastructure and language but were largely not the same people or organisations.

For researchers examining this period, the primary sources are Hansard records from the Australian Senate and the NSW and Victorian parliaments, published reports from government inquiries (especially the 1994 Hall review and the 2000 NSW Working Party), the Norml News archive, and contemporaneous reporting in The Sydney Morning Herald, The Age and the New Zealand Herald. Patient testimony from the HIV/AIDS years is preserved in AIDS Council archives and in the Australian Lesbian and Gay Archives (held at RMIT University).

Sources

How this page was made

Related

• 1990s Rave Culture and Cannabis — Cannabis was secondary to MDMA in early raves but became central to chill-out spaces and d...
• Cannabis Buyers' Clubs of the 1990s — The informal dispensary networks that transformed cannabis from crime to state-legal medic...
• Cannabis Laws in Australia — Medical access is available; recreational use remains illegal except in ACT with limited d...
• Medical Cannabis Advocacy in Australia and New Zealand during the 1940s — The quiet end of cannabis medicine in Australasia, not an era of advocacy.
• Medical Cannabis Advocacy in Australia and New Zealand During the 1950s — No organised medical cannabis advocacy emerged in Australia or New Zealand during the 1950...